◆英語タイトル:Immunodiagnostic Systems Holdings plc (IDH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011111
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月21日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research areas. Its clinical areas include bone metabolism, calcium metabolism, chronic kidney disease and mineral bone disorders, fertility, growth disorders, and cartilage markers. IDS offers IDS-iSYS multi-discipline automated system, an instrument based on chemiluminescence and absorbency technology to improve productivity and efficiency of specialty immunoassay testing in laboratories of all types and volumes. The company offers services such as application training and advice, customized training, qualified customer care centers and regionalised proximity teams. It has operations in the UK, Italy, Australia, Japan, Germany, France, Norway, Belgium and the US. IDS is headquartered in Tyne and Wear, the UK.
Immunodiagnostic Systems Holdings plc (IDH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Immunodiagnostic Systems Holdings plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deal Details 10
Partnerships 10
Omega Diagnostics Enters Into Licensing Agreement With Immunodiagnostic Systems 10
Immunodiagnostic Systems Enters Into Distribution Agreement With Beijing Leadman Biochemistry For IDS-iSYS 11
Immunodiagnostic Systems Enters Into Research And Development Agreement With Beijing Leadman Biochemistry 12
Immunodiagnostic Systems Enters Into Co-Development Agreement With Diagnostica Stago 13
Omega Diagnostics Amends Licensing Agreement With Immunodiagnostic Systems 14
Immunodiagnostic Systems Enters into Licensing Agreement with AnaMar 15
Acquisition 16
Immunodiagnostic Acquires Diametra, Medical Device Company 16
Immunodiagnostic Systems Holdings plc – Key Competitors 17
Immunodiagnostic Systems Holdings plc – Key Employees 18
Immunodiagnostic Systems Holdings plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Nov 24, 2017: Immunodiagnostic Systems Holdings: Unaudited Interim Results for the six month period ended 30 September 2017 21
Oct 20, 2017: Immunodiagnostic Systems Holdings: H1 Trading Update 2017 28
Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017 29
Nov 25, 2016: Immunodiagnostic Systems Holdings: Interim Results for the six month period ended 30 September 2016 30
Oct 21, 2016: Immunodiagnostic Systems Holdings: H1 Trading Update 31
Jun 22, 2016: Immunodiagnostic Systems Holdings Announces Financial Results 33
Jun 09, 2016: Immunodiagnostic Systems Holdings provides update on re royalty revenues 36
Corporate Communications 37
Oct 31, 2017: Immunodiagnostic Systems Holdings: Directorate Change 37
Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO 38
Feb 24, 2017: Immunodiagnostic Systems Holdings: Update on CEO Appointment 39
Jan 19, 2017: Immunodiagnostic Systems Holdings Announces Directorate Change 40
Other Significant Developments 41
Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Immunodiagnostic Systems Holdings plc, Medical Equipment, Key Facts, 2017 2
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Immunodiagnostic Systems Holdings plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Immunodiagnostic Systems Holdings plc, Deals By Market, 2011 to YTD 2017 8
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Omega Diagnostics Enters Into Licensing Agreement With Immunodiagnostic Systems 10
Immunodiagnostic Systems Enters Into Distribution Agreement With Beijing Leadman Biochemistry For IDS-iSYS 11
Immunodiagnostic Systems Enters Into Research And Development Agreement With Beijing Leadman Biochemistry 12
Immunodiagnostic Systems Enters Into Co-Development Agreement With Diagnostica Stago 13
Omega Diagnostics Amends Licensing Agreement With Immunodiagnostic Systems 14
Immunodiagnostic Systems Enters into Licensing Agreement with AnaMar 15
Immunodiagnostic Acquires Diametra, Medical Device Company 16
Immunodiagnostic Systems Holdings plc, Key Competitors 17
Immunodiagnostic Systems Holdings plc, Key Employees 18
Immunodiagnostic Systems Holdings plc, Other Locations 19
Immunodiagnostic Systems Holdings plc, Subsidiaries 19